Immunome, Inc. (IMNM) NASDAQ
19.40
-1.3818(-6.65%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
19.40
-1.3818(-6.65%)
Currency In USD
| Market Cap | 1.88B |
| Enterprise Value | 1.23B |
| P/E Ratio | -9.77 |
| PEG Ratio | -0.34 |
| Price/Sales Ratio | 461.86 |
| Price/Book Ratio | 3.73 |
| Enterprise/Revenue | 317.65 |
| Enterprise/EBITDA | -5.47 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -55.94 |
| Operating Margin | -59.48 |
| Return On Assets | -0.36 |
| Return On Equity | -0.51 |
| Revenue | 6.94M |
| Revenue/Share | 0.04 |
| Gross Profit | 3.99M |
| EBITDA | -211.16M |
| Net Income | -212.39M |
| Diluted EPS | -2.43 |
| Total Cash | 582.69M |
| Total Cash/Share | 5.15 |
| Total Debt | 3.69M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 21.68 |
| Book Value Per Share | 5.2 |
| 52-Week Change | 114.11 |
| 52-Week High | 27.65 |
| 52-Week Low | 7.96 |
| Moving Average 50 Days | 22.13 |
| Moving Average 200 Days | 18.77 |
| Average Volume | 1.2M |
| Shares Outstanding | 95.6M |
| % Held by Institutions | 133.55 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |